This study is in progress, not accepting new patients
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
Diabetic Kidney Disease Type 2 Diabetes Kidney diseases Diabetes Mellitus Diabetes Mellitus, Type 2 Diabetic Nephropathies Finerenone (BAY94-8862) BAY94-8862
Lead Scientist at UCSF
- Ramin Sam
College: University of Illinois-Urbana Medical School: University of Illinois-Chicago Internal Medicine Residency: Loyola University Nephrology Fellowship: Loyola University Interests: My clinical/research interests are varied and include sodium disorders, hemodialysis, acid/base disorders, transjugular kidney biopsies and lipoprotein glomerulonephropathy.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Click here and search for drug information provided by the FDA.
- Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.
- Phase 3
- Study Type
- Last Updated